Agency Information Collection Request. 60-Day Public Comment Request, 16753-16754 [2022-06255]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices
The parties entered into a Voluntary
Settlement Agreement (Agreement) to
conclude this matter without further
expenditure of time, finances, or other
resources. The settlement is not an
admission of liability on the part of the
Respondent.
Respondent voluntarily agreed to the
following:
(1) Respondent will have his research
supervised for a period of twelve (12)
years beginning on March 1, 2022 (the
‘‘Supervision Period’’). Prior to the
submission of an application for PHS
support for a research project on which
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity in PHS-supported
research, Respondent will submit a plan
for supervision of Respondent’s duties
to ORI for approval. The supervision
plan must be designed to ensure the
integrity of Respondent’s research.
Respondent will not participate in any
PHS-supported research until such a
supervision plan is approved by ORI.
Respondent will comply with the
agreed-upon supervision plan.
(2) The requirements for Respondent’s
supervision plan are as follows:
i. A committee of 2–3 senior faculty
members at the institution who are
familiar with Respondent’s field of
research, but not including
Respondent’s supervisor or
collaborators, will provide oversight and
guidance. The committee will review
primary data from Respondent’s
laboratory on a quarterly basis and
submit a report to ORI at six (6) month
intervals setting forth the committee
meeting dates and Respondent’s
compliance with appropriate research
standards and confirming the integrity
of Respondent’s research.
ii. The committee will conduct an
advance review of each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved. The review will include a
discussion with Respondent of the
primary data represented in those
documents and will include a
certification to ORI that the data
presented in the proposed application,
report, manuscript, or abstract is
supported by the research record.
(3) During the Supervision Period,
Respondent will ensure that any
institution employing him submits, in
conjunction with each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved, a certification to ORI that the
data provided by Respondent are based
on actual experiments or are otherwise
legitimately derived and that the data,
VerDate Sep<11>2014
17:39 Mar 23, 2022
Jkt 256001
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract.
(4) If no supervision plan is provided
to ORI, Respondent will provide
certification to ORI at the conclusion of
the Supervision Period that his
participation was not proposed on a
research project for which an
application for PHS support was
submitted and that he has not
participated in any capacity in PHSsupported research.
(5) During the Supervision Period,
Respondent will exclude himself
voluntarily from serving in any advisory
or consultant capacity to PHS including,
but not limited to, service on any PHS
advisory committee, board, and/or peer
review committee.
Dated: March 21, 2022.
Wanda K. Jones,
Acting Director, Office of Research Integrity,
Office of the Assistant Secretary for Health.
[FR Doc. 2022–06247 Filed 3–23–22; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–New]
Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before May 23, 2022.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–New–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
795–7714 the Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
16753
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Health Care
Readiness Collections.
Type of Collection: Revision.
OMB No.: 0990–0391.
Abstract: The Office of the Assistant
Secretary for Preparedness and
Response (ASPR) in the Department of
Health and Human Services (HHS)
administers a portfolio of health care
readiness programs and activities,
including the Hospital Preparedness
Program (HPP) authorized under
Section 319C–2 of the Public Health
Service (PHS) Act. HPP is a cooperative
agreement program that strengthens
national health care readiness, supports
health care resilience, and enables rapid
recovery.
Through the Health Care Readiness
Portfolio, ASPR provides awards to 62
health departments in all 50 states,
territories, freely associated states, and
four metropolitan areas to support the
health care delivery system through
over 320 health care coalitions (HCCs)
with nearly 45,000 members. An HCC is
a network of public and private
organizations that partner to conduct
planning, training, and preparedness
activities within a state or locality,
building that area’s overall readiness.
ASPR’s Health Care Readiness
Portfolio aligns preparedness activities
across health care and also includes the
Regional Disaster Health Response
System (RDHRS) demonstration sites
that establish regional partnerships to
develop promising practices in
coordinating disaster readiness and
regional medical response; the National
Special Pathogen System, a nationwide
systems-based network approach for
special pathogen care; workforce
capacity activities; and other initiatives.
ASPR collects data annually to
understand how federal funding has
been spent, measure performance, and
monitor adherence with program
requirements. These data additionally
support ASPR to develop funding
opportunities, improve programmatic
operations, and inform decision-making.
ASPR is also responsible for allocating
and monitoring emergency and
supplemental funding, understanding
recipient and sub-recipient real-time
needs, and maintaining situational
awareness of the current state of
preparedness, response, and recovery
activities. When circumstances require
rapid information gathering, it is
necessary for ASPR to also collect data
E:\FR\FM\24MRN1.SGM
24MRN1
16754
Federal Register / Vol. 87, No. 57 / Thursday, March 24, 2022 / Notices
on an ad hoc basis to advance these
goals. ASPR is changing the title of this
collection from ‘‘Hospital Preparedness
Program Data Collection’’ to ‘‘Health
Care Readiness Collections’’ to better
reflect the scope of data collected under
this approval.
ANNUALIZED BURDEN HOUR TABLE
HPP Recipient End-of-Year Performance Report Collection.
HPP Sub-Recipient End-of-Year Performance Report Collection.
Ad hoc Information Collections .........
HPP Recipients ................................
62
1
21
1,302
HPP Sub-Recipients ........................
321
1
4
1,284
ASPR Health Care Readiness Portfolio Stakeholders.
5,296
1
1
5,296
Total ...........................................
...........................................................
........................
3
........................
7,882
[FR Doc. 2022–06255 Filed 3–23–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Findings of research
misconduct have been made against
Daniel Leong, Ph.D. (Respondent),
formerly a Research Technician, Albert
Einstein College of Medicine (AECM).
Respondent engaged in research
misconduct in research supported by
U.S. Public Health Service (PHS) funds,
specifically National Institute of
Arthritis and Musculoskeletal and Skin
Diseases (NIAMS), National Institutes of
Health (NIH), grant R01 AR050968 and
National Heart, Lung, and Blood
Institute (NHLBI), NIH, grant P01
HL110900. The administrative actions,
including debarment for a period of four
(4) years followed by supervision for a
period of four (4) years, were
implemented beginning on February 28,
2022, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Wanda K. Jones, Dr.P.H., Acting
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 240,
Rockville, MD 20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Daniel Leong, Ph.D., Albert Einstein
College of Medicine: Based on the report
of an investigation conducted by AECM
and analysis conducted by ORI in its
oversight review, ORI found that Dr.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
Respondents
(If necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
VerDate Sep<11>2014
17:39 Mar 23, 2022
Jkt 256001
Number of
respondents
Number of
responses per
respondents
Forms
(If necessary)
Daniel Leong, formerly a Research
Technician, AECM, engaged in research
misconduct in research supported by
PHS funds, specifically NIAMS, NIH,
grant R01 AR050968 and NHLBI, NIH,
grant P01 HL110900.
ORI found that Respondent engaged
in research misconduct by intentionally,
knowingly, or recklessly falsifying and/
or fabricating data included in sixteen
(16) grant applications submitted for
PHS funds:
• R01 AR065563–01, ‘‘CITED2 and
Chondroprotection,’’ submitted to
NIAMS, NIH, on 02/05/2013.
• R01 AR066009–01, ‘‘Remote
Loading for Osteoarthritis,’’ submitted
to NIAMS, NIH, on 06/04/2013.
• R01 AR065563–01A1, ‘‘CITED2 and
Chondroprotection,’’ submitted to
NIAMS, NIH, on 11/05/2014.
• R41 AR070695–01, ‘‘A novel
product for tendinopathy treatment,’’
submitted to NIAMS, NIH, on 01/05/
2015.
• R01 AG069693–01, ‘‘Chondrocyte
fate regulation and cartilage protection,’’
submitted to National Institute on Aging
(NIA), NIH, on 06/05/2015.
• R01 AG039561–06, ‘‘Human tendon
stem progenitor cell aging and
regeneration,’’ submitted to NIA, NIH,
on 03/15/2016 (original grant funding
from 08/15/2012–04/30/2018).
• R43 AT009414–01, ‘‘A novel
nutraceutical drug for tendinopathy
treatment,’’ submitted to National
Center for Complementary and
Alternative Medicine (NCCAM), NIH,
on 04/05/2016.
• R01 AR070431–01A1, ‘‘The role of
Panx1 in the pathogenesis and pain of
osteoarthritis,’’ submitted to NIAMS,
NIH, on 07/19/2016.
• R41 AG056246–01A1, ‘‘A novel
product for tendinopathy treatment,’’
submitted to NIA, NIH, on 09/06/2016,
funded from 09/15/2017–08/31/2019.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Total burden
hours
• R01 AG056623–01, ‘‘Chondrocyte
fate regulation and osteoarthritis,’’
submitted to NIA, NIH, on 10/05/2016.
• R01 AR072038–01, ‘‘MSC-derived
exosomes and tendon disorders,’’
submitted to NIAMS, NIH, on 10/05/
2016.
• R43 AT009414–01A1, ‘‘A novel
nutraceutical drug for tendinopathy
treatment,’’ submitted to NCCAM, NIH,
on 04/05/2017, funded from 08/01/
2018–07/31/2020.
• R01 AR073194–01, ‘‘Chondrocyte
fate regulation and cartilage protection,’’
submitted to NIAMS, NIH, on 06/05/
2017.
• R01 AR074802–01, ‘‘The role of
Panx1 in the pathogenesis and pain of
osteoarthritis,’’ submitted to NIAMS,
NIH, on 04/02/2018.
• R01 AR074802–01A1, ‘‘The role of
Panx1 in the pathogenesis and pain of
osteoarthritis,’’ submitted to NIAMS,
NIH, on 08/01/2018.
• R44 AG065089–01, ‘‘Botanical drug
for spontaneous osteoarthritis,’’
submitted to NIA, NIH, on 01/07/2019.
ORI found that Respondent
intentionally, knowingly, or recklessly
falsified and/or fabricated Western blot
and histological image data for chronic
deep tissue conditions including
osteoarthritis (OA) and tendinopathy in
murine models by reusing image data,
with or without manipulating them to
conceal their similarities, and falsely
relabeling them as data representing
different experiments in fifty (50)
figures included in sixteen (16) PHS
grant applications. In the absence of
reliable image data, the figures,
quantitative data in associated graphs
purportedly derived from those images,
statistical analyses, and related text also
are false.
Specifically, ORI found that:
1. Respondent reused and relabeled
Western blot images from the same
source to falsely represent different
proteins and/or experimental results in:
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 87, Number 57 (Thursday, March 24, 2022)]
[Notices]
[Pages 16753-16754]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06255]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-New]
Agency Information Collection Request. 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before May 23, 2022.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 795-7714.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], or call (202) 795-7714 the Reports Clearance
Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Health Care Readiness Collections.
Type of Collection: Revision.
OMB No.: 0990-0391.
Abstract: The Office of the Assistant Secretary for Preparedness
and Response (ASPR) in the Department of Health and Human Services
(HHS) administers a portfolio of health care readiness programs and
activities, including the Hospital Preparedness Program (HPP)
authorized under Section 319C-2 of the Public Health Service (PHS) Act.
HPP is a cooperative agreement program that strengthens national health
care readiness, supports health care resilience, and enables rapid
recovery.
Through the Health Care Readiness Portfolio, ASPR provides awards
to 62 health departments in all 50 states, territories, freely
associated states, and four metropolitan areas to support the health
care delivery system through over 320 health care coalitions (HCCs)
with nearly 45,000 members. An HCC is a network of public and private
organizations that partner to conduct planning, training, and
preparedness activities within a state or locality, building that
area's overall readiness.
ASPR's Health Care Readiness Portfolio aligns preparedness
activities across health care and also includes the Regional Disaster
Health Response System (RDHRS) demonstration sites that establish
regional partnerships to develop promising practices in coordinating
disaster readiness and regional medical response; the National Special
Pathogen System, a nationwide systems-based network approach for
special pathogen care; workforce capacity activities; and other
initiatives.
ASPR collects data annually to understand how federal funding has
been spent, measure performance, and monitor adherence with program
requirements. These data additionally support ASPR to develop funding
opportunities, improve programmatic operations, and inform decision-
making. ASPR is also responsible for allocating and monitoring
emergency and supplemental funding, understanding recipient and sub-
recipient real-time needs, and maintaining situational awareness of the
current state of preparedness, response, and recovery activities. When
circumstances require rapid information gathering, it is necessary for
ASPR to also collect data
[[Page 16754]]
on an ad hoc basis to advance these goals. ASPR is changing the title
of this collection from ``Hospital Preparedness Program Data
Collection'' to ``Health Care Readiness Collections'' to better reflect
the scope of data collected under this approval.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Forms (If necessary) Respondents (If Number of responses per Average burden Total burden
necessary) respondents respondents per response hours
----------------------------------------------------------------------------------------------------------------
HPP Recipient End-of-Year HPP Recipients.. 62 1 21 1,302
Performance Report Collection.
HPP Sub-Recipient End-of-Year HPP Sub- 321 1 4 1,284
Performance Report Collection. Recipients.
Ad hoc Information Collections ASPR Health Care 5,296 1 1 5,296
Readiness
Portfolio
Stakeholders.
---------------------------------------------------------------------------------
Total..................... ................ .............. 3 .............. 7,882
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2022-06255 Filed 3-23-22; 8:45 am]
BILLING CODE 4150-28-P
